A phase 3 randomized, placebo‐controlled, double‐blind, clinical trial of the effect of modafinil on cancer‐related fatigue among 631 patients receiving chemotherapy

2010191 citationsJournal Articlegreen Open Access

Authors

Pascal Jean‐Pierre · University of Miami

Gary R. Morrow · University of Rochester Medical Center

Joseph A. Roscoe · University of Rochester Medical Center

Charles E. Heckler · University of Rochester Medical Center

Supriya G. Mohile · University of Rochester Medical Center

Michelle C. Janelsins · University of Rochester Medical Center

Luke J. Peppone

Abstract

Modafinil may be useful in controlling cancer-related fatigue in patients who present with severe fatigue but is not useful in patients with mild or moderate fatigue.

Topics & Keywords

Cancer survivorship and care Cancer-related cognitive impairment studies Cancer Treatment and Pharmacology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cancer

Volume 116, Issue 14, pp. 3513-3520

DOI: 10.1002/cncr.25083

Field-Weighted Citation Impact: 8.48

Command Palette